Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents

Hong Kong Medical Journal

Volumn 23, Issue 3, 2017, Pages 246-250

  So, H ^a   Yuen, Carol S W ^a   Yip, Ronald M L ^a  

^a KWONG WAH HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; HYDROXYCHLOROQUINE; ISONIAZID; LEFLUNOMIDE; METHOTREXATE; PREDNISOLONE; RIFAMPICIN; SALAZOSULFAPYRIDINE; BIOLOGICAL FACTOR;

ADULT; ARTHRITIS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL EVALUATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HONG KONG; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MALE; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SPONDYLARTHRITIS; STEROID THERAPY; THORAX RADIOGRAPHY; TUBERCULIN TEST; ANKYLOSING SPONDYLITIS; COMPARATIVE STUDY; MASS SCREENING; MIDDLE AGED; PROCEDURES; SENSITIVITY AND SPECIFICITY;

ADULT; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; BIOLOGICAL FACTORS; FEMALE; FOLLOW-UP STUDIES; HONG KONG; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MASS SCREENING; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SPONDYLITIS, ANKYLOSING; TUBERCULIN TEST;

EID: 85020253369     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: 10.12809/hkmj164880     Document Type: Article

References (22)

1. Furst DE. The risk of infections with biologic therapies for rheumatoid arthritis. Semin Arthritis Rheum 2010;39:327-46.
2. World Health Organization. Guidelines on the management of latent tuberculosis infection. Geneva, Switzerland: World Health Organization; 2015.
3. Mok CC. Consensus statements on the indications and monitoring of anti-tumor necrosis factor (TNF) therapy for rheumatic diseases in Hong Kong. Hong Kong Bull Rheum Dis 2005;5:19-25.
4. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993;17:968-75.
5. Matulis G, Jüni P, Villiger PM, Gadola SD. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay. Ann Rheum Dis 2008;67:84-90.
6. Ponce de Leon D, Acevedo-Vasquez E, Alvizuri S, et al. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J Rheumatol 2008;35:776-81.
7. Song Q, Guo H, Zhong H, et al. Evaluation of a new interferon-gamma release assay and comparison to tuberculin skin test during a tuberculosis outbreak. Int J Infect Dis 2012;16:e522-6.
8. Ferrara G, Losi M, Meacci M, et al. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2005;172:631-5.
9. Kleinert S, Tony HP, Krueger K, et al. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-gamma release assays under real-life conditions. Ann Rheum Dis 2012;71:1791-5.
10. Mariette X, Baron G, Tubach F, et al. Influence of replacing tuberculin skin test with ex vivo interferon gamma release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy. Ann Rheum Dis 2012;71:1783-90.
11. Winthrop KL, Weinblatt ME, Daley CL. You can’t always get what you want, but if you try sometimes (with two tests—TST and IGRA—for tuberculosis) you get what you need. Ann Rheum Dis 2012;71:1757-60.
12. Cao H, Agrawal D, Kushner N, Touzjian N, Essex M, Lu Y. Delivery of exogenous protein antigens to major histocompatibility complex class I pathway in cytosol. J Infect Dis 2002;185:244-51.
13. McEvers K, Elrefaei M, Norris P, et al. Modified anthrax fusion proteins deliver HIV antigens through MHC class I and II pathways. Vaccine 2005;23:4128-35.
14. Pai M, Zwerling A, Menzies D. Systematic review: T-cell– based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177-84.
15. Yilmaz N, Zehra Aydin S, Inanc N, Karakurt S, Direskeneli H, Yavuz S. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients. Lupus 2012;21:491-5.
16. Lee JH, Sohn HS, Chun JH, et al. Poor agreement between QuantiFERON-TB Gold test and tuberculin skin test results for the diagnosis of latent tuberculosis infection in rheumatoid arthritis patients and healthy controls. Korean J Intern Med 2014;29:76-84.
17. Ewer K, Deeks J, Alvarez L, et al. Comparison of Tcell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003;361:1168-73.
18. Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 2004;170:65-9.
19. Huang YW, Shen GH, Lee JJ, Yang WT. Latent tuberculosis infection among close contacts of multidrug-resistant tuberculosis patients in central Taiwan. Int J Tuberc Lung Dis 2010;14:1430-5.
20. Shalabi NM, Houssen ME. Discrepancy between the tuberculin skin test and the levels of serum interferon-gamma in the diagnosis of tubercular infection in contacts. Clin Biochem 2009;42:1596-601.
21. Mandalakas AM, Hesseling AC, Chegou NN, et al. High level of discordant IGRA results in HIV-infected adults and children. Int J Tuberc Lung Dis 2008;12:417-23.
22. Shahidi N, Fu YT, Qian H, Bressler B. Performance of interferon-gamma release assays in patients with inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis 2012;18:2034-42.